Ascendis Pharma Showcases Its Latest Endocrinology Programs, Data, and Research at ENDO 2023
– Endocrinology clinical development progress and research in growth hormone deficiency, hypoparathyroidism, achondroplasia, and Turner Syndrome will be highlighted – Phase 3 Week 52 data